G-CSF levels in BMSC supernatant were significantly increased in Treg-CM-treated BMSC compared to OM, Non-CM, and BMSC alone at day 0, while VEGF levels in the supernatant were slightly lower in Treg-CM-treated BMSC compared to day 0 (Fig. 7c). This evidence concerns the gene VEGFA and ocular melanoma.